Dr. Burroughs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4800 Sand Point Way Ne
Seattle, WA 98105Phone+1 206-987-2106- Is this information wrong?
Education & Training
- University of WashingtonFellowship, Pediatric Hematology/Oncology, 2001 - 2004
- Indiana University School of MedicineResidency, Pediatrics, 1998 - 2001
- University of Wisconsin School of Medicine & Public HealthClass of 1998
Certifications & Licensure
- WA State Medical License 2001 - 2026
- NC State Medical License 2022 - 2022
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant Start of enrollment: 1997 Aug 11
- Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders Start of enrollment: 2006 May 24
- Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders Start of enrollment: 2006 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsGenotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.Jennifer W Leiding, Danielle E Arnold, Suhag Parikh, Brent Logan, Rebecca A Marsh, Linda M Griffith, Ruizhe Wu, Sharon Kidd, Kanwaldeep Mallhi, Deepak Chellapandian, S...> ;Blood. 2023 Dec 14
- 1 citationsAlemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT.Ashley V Geerlinks, Brooks Scull, Christa Krupski, Ryan Fleischmann, Michael A Pulsipher, Mary Eapen, James A Connelly, Catherine M Bollard, Sung-Yun Pai, Christine N ...> ;Blood Advances. 2023 Jul 25
- 4 citationsRisk factors for severe acute kidney injury after pediatric hematopoietic cell transplantation.Abbie Bauer, Kristen Carlin, Stephen M Schwartz, Meera Srikanthan, Monica Thakar, Lauri M Burroughs, Jodi Smith, Sangeeta Hingorani, Shina Menon> ;Pediatric Nephrology. 2023 Apr 1
- Join now to see all
Journal Articles
- Novel Lineage Depletion Preserves Autologous Blood Stem Cells for Gene Therapy of Fanconi Anemia Complementation Group ALauri M Burroughs, Pamela S Becker, Haematologica
- Reduced Intensity Conditioning for Hematopoietic Cell Transplant for HLH and Primary Immune Deficiencies: BMT CTN 1204Shalini Shenoy, K Scott Baker, Elizabeth O Stenger, Mary Eapen, Carl Allen, Lauri Burroughs, Philip Roehrs, Catherine M Bollard, Rabi Hanna, Jeffrey R Andolina, James ..., Blood
Grant Support
- Nonmyeloablative Allografting For Immunodeficiency &Other Nonmalignant DisordersNational Heart, Lung, And Blood Institute2007–2010
Hospital Affiliations
- Seattle Children's HospitalSeattle, Washington
- UW Medicine/Harborview Medical CenterSeattle, Washington
- UW Medicine/University of Washington Medical CenterSeattle, Washington
- Fred Hutchinson Cancer CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: